Abstract-Lucigenin-amplified chemiluminescence has frequently been used to assess the formation of superoxide in vascular tissues. However, the ability of lucigenin to undergo redox cycling in purified enzyme-substrate mixtures has raised questions concerning the use of lucigenin as an appropriate probe for the measurement of superoxide production. Addition of lucigenin to reaction mixtures of xanthine oxidase plus NADH resulted in increased oxygen consumption, as well as superoxide dismutase-inhibitable reduction of cytochrome c, indicative of enhanced rates of superoxide formation. Additionally, it was revealed that lucigenin stimulated oxidant formation by both cultured bovine aortic endothelial cells and isolated rings from rat aorta. Lucigenin treatment resulted in enhanced hydrogen peroxide release from endothelial cells, whereas exposure to lucigenin resulted in inhibition of endothelium-dependent relaxation in isolated aortic rings that was superoxide dismutase inhibitable. In contrast, the chemiluminescent probe coelenterazine had no significant effect on xanthine oxidase-dependent oxygen consumption, endothelial cell hydrogen peroxide release, or endothelium-dependent relaxation. Study of enzyme and vascular systems indicated that coelenterazine chemiluminescence is a sensitive marker for detecting both superoxide and peroxynitrite. 
S uperoxide (O 2
• ) and other oxidants play a central role in the maintenance of vascular homeostasis and injury. Nitric oxide (⅐NO)-dependent cell signaling, including endothelium-dependent relaxation, is modulated by both O 2
• and superoxide dismutases (SODs), the family of enzymes that catalyze the formation of hydrogen peroxide (H 2 O 2 ) and molecular oxygen from O 2 • . [1] [2] [3] [4] Alterations in both the rates of formation and extents of scavenging of O 2
• have been implicated in the vascular dysfunction seen in atherosclerosis, hypertension, diabetes, and chronic nitrate tolerance. [5] [6] [7] [8] [9] [10] Finally, increased rates of vascular production of O 2 • contribute to the initiation of proinflammatory events, with transcriptional regulation of the gene expression of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 sensitive to changes in cellular oxidant production. 11, 12 Measurement of the vascular production of O 2
• is problematic for several reasons. Low intracellular steady-state concentrations occur as a result of the balance between the endogenous rates of partial reduction of oxygen to O 2 • and the scavenging of O 2
• by highly efficient cytoplasmic and mitochondrial SODs, resulting in intracellular O 2
• concentrations estimated to rarely exceed 10 nmol/L. 13 Extracellular release of small proportions of intracellularly formed O 2 • may occur via diffusion through anion channels. 14, 15 Also, O 2 • formed from plasma membrane-bound oxidases remains at relatively low levels in vascular tissues because of serum and extracellular fluid components, including low molecular weight oxidant scavengers and the heparin-binding extracellular SOD. 3,16 -19 Lucigenin-enhanced chemiluminescence has been used extensively as an indicator of O 2
• production by O 2 • -generating enzyme systems and activated leukocytes 20 -23 and has been adopted for use in the estimation of O 2
• production by cultured cell systems, tissue homogenates, and intact vascular tissue. 2,24 -26 Initial studies of mechanisms of O 2 • -dependent lucigenin chemiluminescence showed that lucigenin must first undergo univalent reduction, before a secondary reaction with O 2 • , to ultimately result in light emission. 27 More recently, lucigenin has been demonstrated to undergo cycles of univalent reduction followed by auto-oxidation to yield O 2 • , thus accelerating rates of O 2
• generation by purified enzymesubstrate complexes. 28 -31 Although no lucigenin-dependent stimulation of cell O 2 • production was apparent from activated macrophages undergoing respiratory burst, 32 this is in contrast to results obtained when low levels of O 2
• were generated, 32 a condition more reflective of oxidant production in both normal and diseased vascular tissues. 
Materials and Methods

Chemicals and Reagents
FCS and iron-supplemented calf serum were acquired from Hyclone. Cell culture reagents were from GIBCO. SOD and 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) were obtained from OXIS, Inc. Coelenterazine was from Molecular Probes. Glucose oxidase (GO) and xanthine oxidase (XO) were obtained from Calbiochem. Manganese tetrakis (N-ethylpyridinium-2-yl)porphyrin (T2E), an SOD mimetic, was a gift from Dr Irwin Fridovich (Duke University). All other chemicals were purchased from Sigma.
Animals
Ten-week-old male Sprague-Dawley rats (300 to 325 g) were obtained from Harlan, Inc (Wilmington, MA), for vascular function analysis. All rats were maintained at constant humidity (60Ϯ5%), temperature (24Ϯ1°C), and light cycle (6 AM to 6 PM) and were fed a standard rat pellet diet (Ralston Purina Diet) ad libitum. All protocols were approved by the Institutional Animal Care and Use Committee at the University of Alabama at Birmingham and were consistent with the Guide for the Care and Use of Laboratory Animals (NIH publication 85-23, revised 1985).
ONOO -Synthesis
ONOO -was synthesized as previously described and treated with MnO 2 to eliminate residual H 2 O 2 . 35 The concentration of ONOO Ϫ was determined spectrophotometrically (⑀ 302 ϭ1.67 mmol/L Ϫ1 ⅐ cm Ϫ1 ), 36 with working solutions of ONOO Ϫ prepared by dilution in 0.1N NaOH and used within 15 minutes.
Biochemical Analyses
XO activity was monitored spectrophotometrically by measuring rates of uric acid production at 295 nm (⑀ϭ11 mmol/L Ϫ1 ⅐ cm Ϫ1 ) in 50 mol/L xanthine and 50 mmol/L potassium phosphate buffer, pH 7.4. GO activity was determined by polarographic measurement of oxygen consumption of 5 to 10 U ⅐ mL Ϫ1 enzyme in 1 mmol/L glucose and 50 mmol/L potassium phosphate buffer, pH 7.4. Extracellular release of H 2 O 2 from BAEC was measured in cells incubated in HBSS by reaction of medium removed from cell monolayers with ammonium ferrous sulfate and potassium thiocyanate. 37, 38 Superoxide generation was measured by the SOD-inhibitable reduction of 10 mol/L oxidized cytochrome c monitored spectrophotometrically at 550 nm, using
Chemiluminescence Measurements
Lucigenin-and coelenterazine-enhanced chemiluminescence was monitored using a Thorn EMI photon counter equipped with an EMI Fact 50 Mk III photomultiplier cooled to -20°C. The voltage in the photomultiplier was kept at 1500 V. Reactions were carried out in continuously stirred glass tubes containing 3-mL reaction volumes maintained at 37°C. Data acquisition and analysis were performed with DQ software (DATAQ Instruments).
Cell Culture
BAECs were cultured in medium 199 with 5% newborn calf serum, 5% iron-supplemented calf serum, 100 U ⅐ mL Ϫ1 penicillin, and 100 g ⅐ mL Ϫ1 streptomycin. Experiments were carried out on subcultured passage 5 to passage 10 cells within 36 hours of reaching confluence. The purity of cultures was determined on the basis of their characteristic cobblestone morphology, positive immunostaining for factor VIII antigen, and selective incorporation of fluorescently labeled acetylated LDL. Cellular protein content was measured by reaction with bicinchoninic acid. 40 
Vessel Reactivity Studies
The effects of lucigenin and coelenterazine on endotheliumdependent relaxation was assessed in isolated rat aortic ring segments. Briefly, the aorta was excised and placed in prewarmed and oxygenated Krebs-Henseleit buffer and dissected free of fat and adhering tissue. Individual ring segments (2 to 3 mm in width) were cut from vessels, and each vascular ring was mounted on 2 stainless steel hooks and suspended from a force-displacement transducer in a water-jacketed tissue bath. The ring was anchored to a hook at the base of the chamber, and a passive load of 2.0 g was applied to vessels. Ring segments were bathed in a Krebs-Henseleit solution of the following composition (in mmol/L): NaCl 118, KCl 4.6, NaHCO 3 27.2, KH 2 PO 4 1.2, MgSO 4 1.2, CaCl 2 1.75, Na 2 -EDTA 0.03, and glucose 11.1 (pH 7.4). The solution was continuously aerated with a 95% O 2 , 5% CO 2 gas mixture unless specified and maintained at 37°C. Changes in isometric tension were measured using capacitative force transducers (Radnoti Glass Technology, Inc). Real-time data were acquired and digitized using an IBMcompatible computer and stored for later analysis using commercially available software (Experimenter's Workbench, Datawave, Inc).
After an equilibration period of 45 minutes, ring segments were depolarized with KCl (70 mmol/L) to determine the contractile capacity of the vessel. Rings were then thoroughly washed and allowed to equilibrate for an additional 45 minutes. All experiments were performed in the presence of indomethacin (5 mol/L) to eliminate the effects of cyclooxygenase-derived vasoactive molecules. In initial studies, ring segments were submaximally contracted with the ␣-adrenergic agonist phenylephrine (PE). When tension development reached a plateau, ⅐NO-dependent relaxation was tested in PE-contracted ring segments by cumulative exposure to acetylcholine (ACh; 1ϫ10 Ϫ9 to 3ϫ10 Ϫ6 mol/L), an endothelium-dependent vasodilator. Vessels were then thoroughly washed and allowed to recover for 1 hour. In the next series of experiments, lucigenin (100 and 250 mol/L) was added to the tissue bath before the initiation of the PE/ACh protocol. No effect of lucigenin on basal arterial tone was noted under these conditions. In some experiments, the effect of lucigenin on ⅐NO-dependent relaxation was assessed in tissues that were treated with 95% compressed air, 5% CO 2 . Recombinant chimeric heparin binding human CuZn SOD (100 U ⅐ mL Ϫ1 ) 10 or native bovine CuZn SOD (200 U ⅐ mL Ϫ1 ) was added in some experiments to the tissue bath 5 minutes before the addition of lucigenin. In parallel experiments, the effects of coelenterazine (10 and 50 mol/L) on ⅐NO-dependent relaxation were also tested. As for experiments studying lucigenin effects on vascular function, coelenterazine was added to the tissue bath before exposure to PE. All experiments were performed in the dark to minimize potential photochemical reactions of buffers, lucigenin, and coelenterazine mediated by fluorescent light.
Vessel Chemiluminescence Studies
Similarly isolated vascular ring segments were incubated with DMNQ (100 mol/L) in the presence or absence of the SOD mimetic MnT2E (100 g ⅐ mL Ϫ1 ) in 50 mmol/L potassium phosphate and 100 mol/L EDTA, pH 7.4, for 3 hours at 37°C. Control rings were incubated with 0.95% ethanol, the vehicle used to dissolve DMNQ. Ring segments were rinsed thoroughly, and 10 mol/L coelenterazine was added to assess vascular chemiluminescence.
Statistical Analysis
Comparisons between groups were made by use of 1-way ANOVA. When significance was indicated, Student-Newman-Keuls post hoc analysis was performed. PϽ0.05 was considered significant.
Results
Lucigenin-Dependent Oxidant Production
To study the effect of lucigenin on low rates of O 2
• formation, as might be expected in vascular tissues in contrast to the high-output O 2 • production associated with activated leukocytes, the reduction of XO by NADH was used as an exemplary reduced flavoprotein. 32 . Addition of coelenterazine (10 and 50 mol/L) had no effect on the rate of XO plus NADH-mediated cytochrome c reduction (data not shown). Table 1 depicts the rates of oxygen consumption by reaction systems under these conditions. Both 20 and 250 mol/L lucigenin enhanced the rate of XO plus NADHdependent oxygen consumption, whereas 10 mol/L coelenterazine had no effect. Lucigenin also mediated direct (ie, O 2
• -independent) cytochrome c reduction by XO, as indicated by the significant fraction (57%) of SOD-resistant cytochrome c reduction ( Figure 1 ). This direct reduction of cytochrome c by lucigenin was also investigated using GO plus glucose, as before. 28 At pH 7.4, GO plus glucose divalently reduces oxygen to H 2 O 2 , with no O 2 • formation detected by assessment of rates of cytochrome c reduction. However, addition of lucigenin resulted in dose-dependent increases in reduction of cytochrome c ( Table 2) . Addition of up to 300 U ⅐ mL Ϫ1 SOD had no effect on rates of cytochrome c reduction, again revealing direct O 2
• -independent electron transfer from lucigenin to cytochrome c. In contrast, up to 
Cytochrome c reduction was followed at 550 nm; reactions were carried out in 50 mmol/L potassium phosphate and 100 mol/L EDTA, pH 7.4. ND indicates not detectable.
50 mol/L coelenterazine did not significantly enhance rates of cytochrome c reduction.
Lucigenin-Enhanced Vascular Production of Oxidants
Endothelial cell monolayer O 2
• production measured via The addition of lucigenin (100 and 250 mol/L) to isolated aortic rings inhibited endothelium-dependent relaxation (Figure 3A) . The presence of SOD in the organ bath restored responsiveness to ACh, indicating lucigenin-enhanced vascular production of O 2
• , which in turn reacted with the added SOD. 5 Because of the concern that the hyperoxic environment (95% O 2 , 5% CO 2 ) in which vascular relaxation studies are typically performed may enhance O 2
• formation 42-44 and artifactually increase vascular reduction of lucigenin and thus rates of formation of partially reduced oxygen species, studies were also conducted in 21% O 2 , 5% CO 2 mixtures, with similar results (not shown). In contrast, addition of coelenterazine to cultured endothelial cells had no effect on extracellular H 2 O 2 release (Table 3) or endothelium-dependent relaxation ( Figure 3B ).
Coelenterazine-Dependent Chemiluminescence
To characterize the utility of coelenterazine as a probe for O 2
• and other biologically relevant oxidants, chemiluminescence experiments were performed. The O 2
• and H 2 O 2 generating system of acetaldehyde and XO was used to limit the accumulation of purine oxidation products (eg, urate) that scavenge ⅐NO-and XO-derived reactive species. 45 Coelenterazine-enhanced chemiluminescence yields were linearly related to coelenterazine concentrations ranging from 0.5 to 3 mol/L (Figure 4 (Figure 5 ). Addition of catalase had no effect on coelenterazine chemiluminescence from acetaldehyde and XO (Figure 6 ), nor did bolus addition of up to 1 mmol/L H 2 O 2 (not shown). In contrast, 20 U ⅐ mL Ϫ1 SOD fully inhibited chemiluminescence ( Figure 6 ). Together, these data confirm that under these conditions coelenterazine chemiluminescence was dependent on O 2 • generation alone and not H 2 O 2 , as previously reported for an XO plus hypoxanthine reaction mixture. 33 Repeated bolus addition of ⅐NO to this O 2 • -generating system resulted in an initial decrease in the chemiluminescent signal, followed by a transient increase ( Figure 7A ). This suggests that ⅐NO inhibits the chemiluminescence yield of O 2
• and coelenterazine, whereas the product of ⅐NO and O 2
• reaction, ONOO Ϫ , also stimulated coelenterazine chemiluminescence. This was confirmed by bolus addition of 10 mol/L ONOO Ϫ , which resulted in a rapid increase and subsequent decay of coelenterazine chemiluminescence (Figure 7B) , whereas the decomposition products of ONOO Ϫ , primarily nitrate and nitrite, did not stimulate chemiluminescence. To test the utility of coelenterazine as a detector of vascular oxidant production, isolated rat aortic segments were incubated with DMNQ, a cell-permeant redox-cycling quinone that stimulates O 2
• and H 2 O 2 production. 46 After a 3-hour incubation, coelenterazine (10 mol/L) was added and chemiluminescence was measured. (Table 2) , 49 and reduced cytochrome c can be reoxidized by cell-derived reactive species such as H 2 O 2 and ONOO Ϫ . 50, 51 Finally, the potential toxicity of some O 2
• probes limits extended application in cell or tissue-based systems, as with some spin traps used for electron paramagnetic resonance spectroscopy. 52 Lucigenin-enhanced chemiluminescence has been used because of its potential to overcome the issues of intracellular access, purported specificity for reaction with O 2
• , and xanthine reaction mixtures or during the oxidative activation of neutrophils or macrophages. 32 The contribution of Equation 3 is significant, however, especially for systems that have lower rates of O 2 • production. 28, 29, 32 It was therefore important to ascertain the potential for lucigenindependent modulation of O 2
• generation in vascular tissues. Influence of lucigenin or coelenterazine on endothelium-dependent relaxation of thoracic aortic rings. A, Lucigenin (100 and 250 mol/L) was added to the tissue bath, and vascular relaxation responses to ACh were determined. CuZn SOD (200 U ⅐ mL Ϫ1 )-restored lucigenin (250 mol/L) inhibited endothelium-dependent relaxation. ࡗPϽ0.05 compared with control; *PϽ0.05 compared with control and 100 mol/L lucigenin. B, Addition of coelenterazine (10 and 50 mol/L) had no effect on the response to ACh. Numbers in parentheses refer to number of animals from which vessels were used to construct curves. Data are meanϮSEM. (Figures 1 and 3 , Tables 1 and   3) . 28, 31, 32 In vascular diseases, there is an enhanced infiltration of inflammatory cells containing high levels of NADPH oxidase and expression by vascular cells of not only neutrophil-like oxidases, but other oxidases as well (eg, 15-lipoxygenase, XO), all capable of mediating direct electron transfer to lucigenin. 9, [53] [54] [55] [56] [57] [58] [59] [60] Within an intact cellular or tissue environment, it has not been determined with precision the enzyme(s) that are responsible for the observed "lucigenin reductase" activity. Thus, in conditions that have been associated with elevated lucigenin chemiluminescence, the apparent increase in rates of O 2
• production may in part be due to enhanced rates of direct reduction of lucigenin by electron transfer systems, rather than a true increase in tissue O 2
• generation. For example, the hypercholesterolemic rabbit, a model for atherosclerosis, displays an increase in vascular XO activity 59 and enhanced lucigenin-dependent chemiluminescence, 25, 59, 61 with increased rates of vascular O 2
• production proposed on the basis of these increases in lucigenin chemiluminescence. Importantly, other lines of evidence also infer an actual increase in steady-state O 2
• concentrations in this model, such as the partial normalization of impaired endothelium-dependent relaxation by cell-permeant SODs and inhibitors of XO. 5, 62 However, the present observations reveal that it is not feasible to estimate actual rates of vascular O 2
• production using lucigenin. It remains possible that lucigenin chemiluminescence may serve as a nonspecific redox-sensitive marker for the enhanced electron transfer activities that are present in various pathologies, with the caveat that (from the present and previous observations) the 
estimation of O 2
• formation from such electron transfer processes may be artifactually enhanced. This is especially the case for mitochondria, organelles rich in flavoproteins that can directly reduce lucigenin to the mono-cation radical. This will enhance nonrespiratory mitochondrial oxygen consumption 32 because of lucigenin-mediated redirection of reducing equivalents to O 2 • and H 2 O 2 formation. 30 Thus, it would be expected that a significant fraction of mitochondrial lucigenin-dependent chemiluminescence is due to direct respiratory chain reduction of lucigenin, extramitochondrial diffusion of the mono-cation radical, and subsequent autooxidation to O 2
• . This lucigenin-dependent chemiluminescence would be inhibitable by various electron transport and flavoprotein inhibitors, as well as by exogenously added SOD. 63 Added SOD would not be expected to inhibit lucigenin chemiluminescence induced by "true" respiratory chainderived O 2 • , since it is a mitochondria-impermeable macromolecule and would not be anticipated to outcompete the already significant levels of respiratory chain-associated endogenous mitochondrial MnSOD. Coelenterazine is a lipophilic luminophore originally isolated from the coelenterate Aequorea and is the lightproducing chromophore in the aequorin complex. 64 Coelenterazine and its analogs, including CLA (2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-␣] pyrazin-3-one) and MCLA (2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-␣] pyrazin-3-one), have been used to reflect O 2
• production in both purified enzyme reactions and activated leukocytes. 33, [65] [66] [67] Studies of the chemical nature of the excited species responsible for the chemiluminescence of pyrazin-3-one compounds are incomplete but suggest that O 2 • -stimulated chemiluminescence occurs after direct oxidation to the acetamidopyrazine anion, which can then also be protonated to form additional neutral light-emitting excited species. 68 There has not been a systematic evaluation of the potential for coelenterazine or its analogs to undergo cycles of reduction and reoxidation analogous to lucigenin, nor has there been a description of the impact of other reactive species such as ⅐NO or ONOO Ϫ on coelenterazine-dependent chemiluminescence. Unlike lucigenin, there was no apparent enhancement of O 2
• generation by coelenterazine in vessel preparations, using the exquisitely sensitive modulation of ⅐NO-dependent signaling by O 2
• as an indicator ( Figure 3B ).
Similar benefits have been observed for the coelenterazine analog, CLA. 69 Additional confirmation that coelenterazine does not undergo cyclic auto-oxidation reactions comes from lack of an effect by coelenterazine on rates of partial reduction of oxygen by XO and cultured vascular endothelial cells (Tables 1 and 3 ). In aggregate, these observations support the concept that coelenterazine-dependent chemiluminescence is an oxidative process that does not require an initial reduction of the luminescent probe. 66, 68 The linear correlations between peak chemiluminescence response, coelenterazine concentrations between 0.5 and 3 mol/L, and rates of SOD-inhibitable O 2
• generation demonstrate that coelenterazine is indeed a sensitive indicator of O 2
• (Figures 4 through 6) . The coelenterazine chemiluminescence responses to ⅐NO and ONOO Ϫ illustrate the care that must be exercised when interpreting the measurement of reactive species in biological tissues ( Figure 7A and 7B) . In systems in which there is the likelihood of cogeneration of both O 2
• and ⅐NO, additional control reactions using SODs, ⅐NO synthase inhibitors, and ONOO Ϫ scavengers, such as urate, ebselen, or metalloporphyrins, 34, 70 must be performed to differentiate the reactive species responsible for coelenterazine chemiluminescence.
In summary, the use of lucigenin-enhanced chemiluminescence to estimate rates of O 2
• formation in vascular tissue must be viewed with caution, as its ability to undergo cycles of reduction and oxidation contributes to O 2 • production, ϩDMNQ (100 mol/L) 54384Ϯ8770* † ϩDMNQ (100 mol/L)ϩMnT2E (100 g ⅐ mL
Ϫ1
) 9715Ϯ1723
Rat aortic segments were incubated in 50 mmol/L potassium phosphate and 100 mol/L EDTA (pH 7.4) with or without DMNQ (100 mol/L) for 3 hours at 37°C and rinsed thoroughly; this was followed by addition of coelenterazine, and chemiluminescence followed for 10 minutes. Data are meanϮSEM of at least 3 rings each from 2 animals. *PϽ0.05 vs control; †PϽ0.05 vs DMNQϩMnT2E.
confirming previous studies using purified enzyme-substrate reaction mixtures. 28, 29, 31 Additionally, the properties of oxidant-dependent coelenterazine chemiluminescence suggest its utility as a sensitive and more reliable alternative probe in place of lucigenin for the detection of O 2
• and related oxidants in biological systems.
